Kala Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$4.41 | -$4.41 | -$4.41 |
| Q2 2024 | 1 | -$2.43 | -$2.43 | -$2.43 |
| Q3 2024 | 1 | -$2.44 | -$2.12 | -$2.28 |
| Q1 2025 | 1 | -$2.43 | -$2.21 | -$2.33 |
| Q2 2025 | 1 | -$1.67 | -$1.67 | -$1.67 |
| Q3 2025 | 1 | -$1.38 | -$1.38 | -$1.38 |
| Q4 2025 | 1 | -$1.31 | -$1.31 | -$1.31 |
Kala Pharmaceuticals, Inc. Earnings Date And Information
Kala Pharmaceuticals, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-3.16 earnings per share for the quarter, topping analysts' consensus estimates of $-4.41 by $1.25. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Kala Pharmaceuticals, Inc. has generated $-17 earnings per share over the last year ($-17.35 diluted earnings per share) and currently has a price-to-earnings ratio of -0.78. Kala Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based on prior year's report dates.
Kala Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$1.93 | $0 | $0 | ||
| 08/06/2024 | Q2 2024 | -$4.41 | -$3.16 | 1.25 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$2.89 | -$4.20 | -1.31 | $0 | |
| 03/29/2024 | Q4 2023 | -$3.62 | -$3.18 | 0.44 | $70,000 | |
| 11/13/2023 | Q3 2023 | -$2.15 | -$3.41 | -1.26 | $2.50 M | $0 |
| 08/04/2023 | Q2 2023 | -$3.19 | -$4.36 | -1.17 | $0 | |
| 05/09/2023 | Q1 2023 | -$5.10 | -$9.04 | -3.94 | $0 | |
| 03/03/2023 | Q4 2022 | -$6.56 | -$8.60 | -2.04 | $1.23 M | |
| 11/08/2022 | Q3 2022 | $10.75 | $19.39 | 8.64 | $62.50 M | $420,000 |
| 08/11/2022 | Q2 2022 | -$22.00 | -$18.50 | 3.5 | $2.02 M | $2.10 M |
| 05/16/2022 | Q1 2022 | -$18.00 | -$22.41 | -4.41 | $1.37 M | |
| 03/29/2022 | Q4 2021 | -$21.50 | -$36.56 | -15.06 | $1.86 M | |
| 11/15/2021 | Q3 2021 | -$22.50 | -$21.62 | 0.88 | $4.97 M | $3.07 M |
| 08/05/2021 | Q2 2021 | -$22.00 | -$28.27 | -6.27 | $5.25 M | $3.05 M |
| 05/05/2021 | Q1 2021 | -$25.50 | -$24.66 | 0.84 | $3.27 M | |
| 02/25/2021 | Q4 2020 | -$23.00 | -$27.33 | -4.33 | $2.24 M | |
| 11/05/2020 | Q3 2020 | -$22.00 | -$24.94 | -2.94 | $2.01 M | $2.22 M |
| 08/06/2020 | Q2 2020 | -$21.00 | -$20.92 | 0.08 | $733,214 | $833,000 |
| 05/07/2020 | Q1 2020 | -$25.50 | -$26.93 | -1.43 | $1.07 M | |
| 02/12/2020 | Q4 2019 | -$30.00 | -$31.46 | -1.46 | $1.18 M |
Kala Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Kala Pharmaceuticals, Inc.'s earnings date?
Kala Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates.
-
Did Kala Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Kala Pharmaceuticals, Inc. (:KALA) reported $-3.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.41 by $1.25.
-
How can I listen to Kala Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Kala Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Kala Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Kala Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Kala Pharmaceuticals, Inc. generate each year?
Kala Pharmaceuticals, Inc. (:KALA) has a recorded net income of $0. Kala Pharmaceuticals, Inc. has generated $-17.35 earnings per share over the last four quarters.
-
What is Kala Pharmaceuticals, Inc.'s price-to-earnings ratio?
Kala Pharmaceuticals, Inc. (:KALA) has a price-to-earnings ratio of -0.78 and price/earnings-to-growth ratio is -0.07.
